Jakko Nieuwenhuijzen

DR.

20102020

Research output per year

If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

177Lutetium PSMA-radioligandtherapie bij prostaatkanker

Translated title of the contribution: 177Lutetium PSMA radioligand therapy in prostate cancer Vis, A. N., Jansen, B. H. E., Bodar, Y. J. L., Nieuwenhuijzen, J. A., Hendrikse, H. N. & Oprea-Lager, D. E., 14 Jan 2020, In : Tijdschrift voor Urologie.

Research output: Contribution to journalArticleProfessional

Open Access

Adding multiparametric MRI to the MSKCC and Partin nomograms for primary prostate cancer: Improving local tumor staging?

Jansen, B. H. E., Nieuwenhuijzen, J. A., Oprea-Lager, D. E., Yska, M. J., Lont, A. P., van Moorselaar, R. J. A. & Vis, A. N., 1 Mar 2019, In : Urologic Oncology. 37, 3, p. 181.e1-181.e6

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

A two-gene methylation signature for the diagnosis of bladder cancer in urine

Bosschieter, J., Nieuwenhuijzen, J. A., Hentschel, A., van Splunter, A. P., Segerink, L. I., Vis, A. N., Wilting, S. M., Lissenberg-Witte, B. I., A van Moorselaar, R. J. & Steenbergen, R. D., Feb 2019, In : Epigenomics. 11, 3, p. 337-347 11 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access